Publicaciones en las que colabora con Pablo Aguiar Fernández (11)

2024

  1. Partial volume correction in longitudinal tau PET studies: is it really needed?

    NeuroImage, Vol. 289

  2. Quantitative brain [18F]FDG PET beyond normal blood glucose levels

    NeuroImage, Vol. 300

2023

  1. Association of periodontitis with cognitive decline and its progression: Contribution of blood-based biomarkers of Alzheimer's disease to this relationship

    Journal of Clinical Periodontology, Vol. 50, Núm. 11, pp. 1444-1454

2021

  1. In Vivo Induction of P-Glycoprotein Function can be Measured with [18F]MC225 and PET

    Molecular Pharmaceutics, Vol. 18, Núm. 8, pp. 3073-3085

2020

  1. -FMISO PET/MRI Imaging Shows Ischemic Tissue around Hematoma in Intracerebral Hemorrhage

    Molecular Pharmaceutics, Vol. 17, Núm. 12, pp. 4667-4675

  2. Periodontitis and vascular inflammatory biomarkers: an experimental in vivo study in rats

    Odontology, Vol. 108, Núm. 2, pp. 202-212

  3. Test-Retest Repeatability of [18F]MC225-PET in Rodents: A Tracer for Imaging of P-gp Function

    ACS Chemical Neuroscience, Vol. 11, Núm. 4, pp. 648-658

2019

  1. Porphyromonas gingivalis lipopolysaccharide-induced periodontitis and serum amyloid-beta peptides

    Archives of Oral Biology, Vol. 99, pp. 120-125

2017

  1. Positron emission tomography for the development and characterization of corneal permanence of ophthalmic pharmaceutical formulations

    Investigative Ophthalmology and Visual Science, Vol. 58, Núm. 2, pp. 772-780

  2. Theragnostic approach for early diagnosis of Alzheimer's disease

    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY

2016

  1. Impact of benzodiazepines on brain FDG-PET quantification after single-dose and chronic administration in rats

    Nuclear Medicine and Biology, Vol. 43, Núm. 12, pp. 827-834